UBS Group AG has hired three investment bankers specializing in biotechnology from RBC Capital Markets as the bank looks to expand its health-care dealmaking in the US.
Siemens (0P6M – Research Report) received a Hold rating and a €240.00 price target from Deutsche Bank analyst Gael De-Bray today. The ...
Brokers say investors, including U.S. and European distressed asset managers, are more interested in exposure to Russia's ...
UBS analyst Andrew Jones CFA maintained a Hold rating on Salzgitter (0G77 – Research Report) today and set a price target of €19.00. The ...
And France’s Credit Mutuel Alliance Federale is buying Oldenburgische Landesbank. From Bloomberg: UBS Group AG is reportedly ...
Stocks rose on Wednesday after the Federal Reserve indicated two rate cuts are still in its forecast for 2025.
Patricia Industries' subsidiary Advanced Instruments, a manufacturer of analytical instruments for the biopharmaceutical and ...
ZURICH (Reuters) -Swiss drugmaker Roche has abandoned global diverse workforce targets and compatriot Novartis is ending its ...
Gold hit another record high above $3,000 on Tuesday, with investors seeking the metal as a haven from risk as conflict ...
European markets are heading for a higher open, with investor focus on the German government as it votes on historic debt ...
JPMorgan Chase & Co. hired UBS Group AG managing director Jens Becker as the bank continues to build its mergers and ...
Swiss bank UBS scrapped references to establishing women in management roles and hiring employees from ethnic minority ...